Nutrien (NTR)
(Delayed Data from NYSE)
$52.55 USD
+0.50 (0.96%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $52.54 -0.01 (-0.02%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$52.55 USD
+0.50 (0.96%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $52.54 -0.01 (-0.02%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth F Momentum B VGM
Zacks News
Nutrien (NTR) Gains on Strong Demand Amid Pricing Woes
by Zacks Equity Research
While Nutrien (NTR) faces pricing headwinds, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
by Zacks Equity Research
While Nutrien (NTR) faces challenges from softer fertilizer prices, it gains on strong demand for crop nutrients on the strength in global agriculture markets.
How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nutrien (NTR) Down 1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nutrien (NTR) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Nutrien (NTR) stood at $53.09, denoting a -1.1% change from the preceding trading day.
Is It Worth Investing in Nutrien (NTR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nutrien (NTR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Nutrien (NTR) Declares TSX Clearance of Shares Buyback Program
by Zacks Equity Research
Nutrien (NTR) receives approval for a new share repurchase program, allowing it to buy back up to 5% of outstanding shares to return capital to shareholders.
Nutrien (NTR) Ups Quarterly Dividend, Announces Share Buyback
by Zacks Equity Research
The board of Nutrien (NTR) authorizes the purchase of up to 5% of the company's issued and outstanding common shares over a 12-month period.
Nutrien's (NTR) Q4 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Nutrien (NTR) earnings miss and sales beat their respective estimates amid lower selling prices across all segments in Q4.
Nutrien (NTR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nutrien (NTR) Q4 Earnings Lag Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -48.61% and 8.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Nutrien (NTR) This Earnings Season?
by Zacks Equity Research
Nutrien (NTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nutrien (NTR) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien (NTR) is expected to have benefited from healthy demand for fertilizers and its cost and operational efficiency initiatives amid headwinds from weaker prices in Q4.
Celanese (CE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q4.
Mosaic (MOS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Mosaic's (MOS) Q4 results are likely to reflect favorable demand for phosphate and potash amid headwinds from weaker fertilizer prices.
Curious about Nutrien (NTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Nutrien (NTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Nutrien (NTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nutrien (NTR) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Nutrien (NTR) closed at $50.06 in the latest trading session, marking a +1.93% move from the prior day.
Barrick (GOLD) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Barrick's (GOLD) fourth-quarter results are expected to have benefited from sequentially higher gold production and prices.
Albemarle (ALB) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher lithium volumes and its cost-reduction actions in Q4 amid demand headwinds in specialties.
CF Industries (CF) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
CF Industries' (CF) fourth-quarter results are likely to reflect the impacts of softer nitrogen prices.
Scotts Miracle-Gro (SMG) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of 10.49% and 3.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Nutrien (NTR) reachead $50.12 at the closing of the latest trading day, reflecting a -1.71% change compared to its last close.
DuPont (DD) Warms Up to Q4 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont's (DD) fourth-quarter results are likely to reflect the impacts of demand softness and inventory de-stocking.
Air Products (APD) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Air Products (APD) is expected to have gained from cost-improvement and productivity initiatives, higher volumes in Americas and pricing actions in Q1.